H.R. 4369 — 117th Congress
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Sponsor
More bills from this sponsor
117th Congress| Measure | Title |
|---|---|
| H.R. 7666 · Health | Restoring Hope for Mental Health and Well-Being Act of 2022 |
Latest action
Oct 20, 2021Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS summary
As of Oct 19, 2021Passed House
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Congressional Research Service, via api.congress.gov (public domain)
Roll-call votes
1 on recordOct 19, 2021 · On Motion to Suspend the Rules and Pass, as Amended
Full roll callYea — 368: 217 D · 151 R
Nay — 56: 56 R
Not Voting — 7: 5 R · 2 D
| Member | State |
|---|---|
| Maxine Waters | CA |
| Emanuel Cleaver | MO |
| Gary J. Palmer | AL |
| Doug LaMalfa | CA |
| Stephanie I. Bice | OK |
| Tom Cole | OK |
| Kevin Brady | TX |
Member pages currently show roll-call votes from the 119th Congress only. The “Member pages” column marks votes from that congress.